Naunyn-Schmiedeberg's archives of pharmacology

Analysis of Extra Heartbeats Reported with Semaglutide in Global and US Safety Databases

Updated

Abstract

1980 semaglutide-associated cardiovascular reports were analyzed, revealing a notable association with ventricular extrasystoles.

  • Ventricular extrasystoles, a type of irregular heartbeat, was the only cardiovascular term to show a significant reporting signal in both VigiBase and the FDA Adverse Event Monitoring System.
  • The reporting odds ratio for ventricular extrasystoles was 1.77 (95% CI 1.31-2.40) in VigiBase and 1.37 (95% CI 1.00-1.88) in AEMS.
  • These findings indicate a higher-than-expected number of reports of ventricular extrasystoles related to semaglutide compared to other cardiovascular events.
  • The results suggest the need for further investigation into the relationship between semaglutide and ventricular extrasystoles using systematic monitoring techniques.
  • While the analysis highlights a potential association, it does not confirm incidence or causality due to the nature of spontaneous reporting data.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free